Hernia Mesh Products Need More Accurate, Detailed Labels: Study

New research suggests that doctors are not getting enough information about the properties and potential risks with hernia mesh patches, indicating that standardized package labeling are needed. 

The study was published online by the Journal of the American College of Surgeons last month, indicating that hernia mesh label information should provide uniform guidelines and greater scrutiny, in order to help doctors select the correct mesh for their patients.

Researchers from Washington University at the St. Louis School of Medicine looked at labeling guidelines and the requirements for the FDA’s 510(k) fast-track approval process, through which most hernia mesh products are approved. They also compared mesh packaging and Instructions For Use (IFUs) provided to doctors for commonly available hernia meshes.

Hernia Mesh Lawsuits

Did you or a loved one receive a hernia mesh?

Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery.

Learn More See If You Qualify For Compensation

According to the findings, medical devices overall, and hernia mesh products in particular, appear to lack the critical scrutiny and detailed specifications of things like food labels.

Researchers found that only 33% of the product labels investigated gave doctors information on composition of the hernia mesh. In addition, only 31% of IFUs provided doctors with information on the mechanics of the mesh, and only 11% indicated the mesh’s thickness. They also found that mechanics and pore size lacked consistent descriptive terms.

“While standardized terminology has been proposed in literature, property knowledge has not adequately permeated surgery, industry, or regulatory guidelines,” the researchers concluded. “There is an extreme underreporting and lack of consistency of clinically important mesh properties. Standardized packaging labels will provide accessibility of these properties and aim to bring standardized terminology into practice. With an increase in access to important properties, this can facilitate intraoperative decision making on a case-by-case basis.”

Hernia Mesh Litigation

The study comes at a time when medical device manufacturers face a growing number of hernia mesh lawsuits filed in courts nationwide over design defects associated with several different widely used products.

Most of the current cases filed in courts nationwide involve Atrium C-Qur lawsuits or Ethicon Physiomesh lawsuits, the latter of which involve a product that was removed from the market last year amid reports of problems.

The Atrium C-Qur, pronounced “Secure”, was approved by the FDA in March 2006, featuring a polypropylene mesh with an outer coating of gel made from 3 fatty acids. However, this design has been linked to reports of severe infections, allergic reactions and other problems.

Ethicon Physiomesh was introduced in March 2010, featuring a unique, multilayered design that was intended to improve performance. However, amid a high number of failures, an Ethicon Physiomesh recall was issued in May 2016, removing the product from the market worldwide. While the action was classified as a “market withdrawal” in the United States, the manufacturer has indicated that it will not be returning the product to the market.

As lawyers continue to review and evaluate claims for individuals who have experienced complications following hernia repair surgery, additional products have also been named in different complaints.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal
BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal (Posted yesterday)

Days after the FDA announced a BioZorb recall, an Arkansas woman has filed a lawsuit, indicating that her BioZorb tissue marker migrated out of position, causing pain and disfigurement, instead of harmlessly absorbing into the body as advertised.

Judge Outlines Suboxone Tooth Decay Lawsuit Census Requirements
Judge Outlines Suboxone Tooth Decay Lawsuit Census Requirements (Posted 2 days ago)

To help the parties identify Suboxone lawsuits that can be used as representative samples in early bellwether trials, the federal judge presiding over the litigation has directed the parties to conduct a census of all tooth decay claims.